1 week Ago By ABMN Staff
Equities research analysts at StockNews.com assumed coverage on shares of Ayala Pharmaceuticals ( NASDAQ:ADXS – Get Free Report ) in a research report issued to clients and investors on Sunday. The firm set a “sell” rating on the stock.
Ayala Pharmaceuticals Price Performance Ayala Pharmaceuticals stock opened at $0.03 on Friday. The firm has a market capitalization of $1.
15 million, a P/E ratio of 0.00 and a beta of 1.62.
The stock has a fifty day moving average price of $0.04 and a two-hundred day moving average price of $0.06.
Ayala Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $1.49.
Ayala Pharmaceuticals Company Profile ( Get Free Report ) Further Reading Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter ..
